Diverticulitis Disease Market Report 2026
Diverticulitis Disease Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Diverticulitis Disease Market Report 2026

Global Outlook – By Type (Uncomplicated, Complicated), By Diagnosis (Computed Tomography (Ct) Scan, Ultrasound, Urine Test, Blood Test), By Treatment (Medications, Surgery, Supportive Care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (Iv) Fluids), By End-User (Specialty Centers, Hospitals, Research Centers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Diverticulitis Disease Market Overview

• Diverticulitis Disease market size has reached to $2.02 billion in 2025

• Expected to grow to $3.22 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%

• Growth Driver: Smoking's Role In Fueling Diverticulitis Market Growth

• Market Trend: Innovative Drug Development Spurs Advances In Diverticulitis Treatments

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Diverticulitis Disease Market?

Diverticulitis disease refers to a medical condition characterized by inflammation or infection of small pouches that develop in the walls of the colon or large intestine. The symptoms of diverticular disease include lower abdominal pain, constipation, diarrhea and rectal bleeding.

The main types of diverticulitis disease are uncomplicated and complicated. Uncomplicated diverticulitis refers to a medical condition characterized by inflammation or infection of small pouches (diverticula) that can form in the walls of the colon. The types of diagnosis are included, such as computed tomography (CT) scans, ultrasounds, urine tests and blood tests, that includes treatments types such as medications, surgery, supportive care, penicillin antibiotic, antibiotics, dietary supplements and intravenous (IV) fluids. It is used by several end-users, such as specialty centers, hospitals and research centers.

Diverticulitis Disease Market Global Report 2026 Market Report bar graph

What Is The Diverticulitis Disease Market Size and Share 2026?

The diverticulitis disease market size has grown strongly in recent years. It will grow from $2.02 billion in 2025 to $2.21 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to aging population growth, low fiber dietary habits, limited early diagnosis, hospital-centric treatment models, rising gastrointestinal disorder prevalence.

What Is The Diverticulitis Disease Market Growth Forecast?

The diverticulitis disease market size is expected to see strong growth in the next few years. It will grow to $3.22 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to preventive digestive health awareness, improved imaging access, outpatient care expansion, reduced surgical intervention rates, focus on lifestyle modification. Major trends in the forecast period include increasing diagnosis of uncomplicated diverticulitis cases, rising preference for conservative and outpatient management, growing use of imaging-based diagnostic techniques, expansion of antibiotic and supportive care treatment, higher awareness of dietary and lifestyle management.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Diverticulitis Disease Market Segmentation

1) By Type: Uncomplicated, Complicated

2) By Diagnosis: Computed Tomography (Ct) Scan, Ultrasound, Urine Test, Blood Test

3) By Treatment: Medications, Surgery, Supportive Care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (Iv) Fluids

4) By End-User: Specialty Centers, Hospitals, Research Centers

Subsegments:

1) By Uncomplicated: Outpatient Treatment, Dietary Management, Antibiotic Therapy

2) By Complicated: Hospitalization, Surgical Intervention, Intravenous Antibiotics, Abscess Drainage

What Are The Drivers Of The Diverticulitis Disease Market?

The rising prevalence of smoking addiction is expected to propel the growth of the diverticulitis disease market going forward. Smoking addiction refers to the compulsive dependence on nicotine-containing products such as cigarettes, vapes, and other tobacco items. The prevalence of smoking addiction is increasing due to aggressive marketing, greater social acceptability, stress-related triggers, and the expanding availability of e-cigarettes and vaping devices. Diverticulitis treatment supports this trend because smoking reduces blood flow to the colon and increases the risk and severity of diverticular disease, thereby elevating the need for diagnosis and therapeutic management. For instance, in October 2024, according to the European Respiratory Society's (ERS), a Switzerland-based non-profit organization, a study covering smoking trends among young people revealed a significant rise in smoking rates, with 22.5% of respondents smoking in 2022 compared to 40.1% in 2024.Therefore, the rising prevalence of smoking addiction will drive the growth of the diverticulitis disease industry.

The increasing prevalence of diabetes is expected to propel the growth of the diverticulitis disease market going forward. Diabetes refers to a chronic metabolic disorder characterized by elevated blood glucose levels resulting from impaired insulin production or utilization. The increasing prevalence of diabetes is primarily driven by unhealthy diets high in processed foods, sedentary lifestyles, rising obesity rates, and aging populations. Diverticulitis disease market supports this trend by addressing diabetes-related complications, as high blood glucose weakens blood vessels and increases colon susceptibility to infections and inflammation, thereby increasing the demand for diagnostic and therapeutic interventions. For instance, in June 2024, according to the National Health Service (NHS England), a UK-based publicly funded healthcare system, in 2023 the number of individuals identified with pre-diabetes increased to 3,615,330, representing an 18% rise from 3,065,825 in 2022, and among people under 40, cases rose nearly 25% from 173,166 in 2022 to 216,440 in 2023. Therefore, the increasing prevalence of diabetes is driving the growth of the diverticulitis disease industry.

Key Players In The Global Diverticulitis Disease Market

Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

Global Diverticulitis Disease Market Trends and Insights

Major companies operating in the diverticulitis disease market are developing innovative drugs and getting them approved to sustain their position in the market. Drug development can lead to the development of more effective treatments for diverticulitis, reducing the risk of complications and improving patient outcomes. For instance, in April 2023, the United States Food and Drug Administration, a US-based federal organization, approved Seres' microbiota drug for recurrent gut infections. This drug is designed to treat recurring gut infections and prevent the recurrence of Clostridioides difficile (C. diff.) infections in adults aged 18 and over. The approval of Vowst was based on a clinical trial that enrolled 346 patients with recurrent CDI. The trial found that patients who received Vowst were significantly less likely to experience a recurrence of the infection than those who received a placebo. The drug is taken orally and is based on microbiota containing Firmicutes spores, which are known to contribute to a healthy microbiome that can resist C. diff. colonization..

Need data on a specific region in this market?

Regional Outlook

North America was the largest region in the diverticulitis disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diverticulitis Disease Market?

The diverticulitis disease market consists of revenues earned by entities by providing diagnostic services, pain management, nutritional therapy and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diverticulitis disease market also includes sales of antibiotics, dietary supplements, high-fiber foods and pain medications. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Diverticulitis Disease Market Report 2026?

The diverticulitis disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diverticulitis disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Diverticulitis Disease Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.21 billion
Revenue Forecast In 2035 $3.22 billion
Growth Rate CAGR of 9.0% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Diagnosis, Treatment, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Diverticulitis Disease Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Diverticulitis Disease Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Diverticulitis Disease Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Diverticulitis Disease Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Diagnosis Of Uncomplicated Diverticulitis Cases

4.2.2 Rising Preference For Conservative And Outpatient Management

4.2.3 Growing Use Of Imaging-Based Diagnostic Techniques

4.2.4 Expansion Of Antibiotic And Supportive Care Treatment

4.2.5 Higher Awareness Of Dietary And Lifestyle Management

5. Diverticulitis Disease Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Centers

5.3 Gastroenterology Clinics

5.4 Diagnostic Centers

5.5 Research Centers

6. Diverticulitis Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Diverticulitis Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Diverticulitis Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Diverticulitis Disease Market Size, Comparisons And Growth Rate Analysis

7.3. Global Diverticulitis Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Diverticulitis Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Diverticulitis Disease Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Diverticulitis Disease Market Segmentation

9.1. Global Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Uncomplicated, Complicated

9.2. Global Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Computed Tomography (Ct) Scan, Ultrasound, Urine Test, Blood Test

9.3. Global Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medications, Surgery, Supportive Care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (Iv) Fluids

9.4. Global Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Specialty Centers, Hospitals, Research Centers

9.5. Global Diverticulitis Disease Market, Sub-Segmentation Of Uncomplicated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Outpatient Treatment, Dietary Management, Antibiotic Therapy

9.6. Global Diverticulitis Disease Market, Sub-Segmentation Of Complicated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitalization, Surgical Intervention, Intravenous Antibiotics, Abscess Drainage

10. Diverticulitis Disease Market Regional And Country Analysis

10.1. Global Diverticulitis Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Diverticulitis Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Diverticulitis Disease Market

11.1. Asia-Pacific Diverticulitis Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Diverticulitis Disease Market

12.1. China Diverticulitis Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Diverticulitis Disease Market

13.1. India Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Diverticulitis Disease Market

14.1. Japan Diverticulitis Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Diverticulitis Disease Market

15.1. Australia Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Diverticulitis Disease Market

16.1. Indonesia Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Diverticulitis Disease Market

17.1. South Korea Diverticulitis Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Diverticulitis Disease Market

18.1. Taiwan Diverticulitis Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Diverticulitis Disease Market

19.1. South East Asia Diverticulitis Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Diverticulitis Disease Market

20.1. Western Europe Diverticulitis Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Diverticulitis Disease Market

21.1. UK Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Diverticulitis Disease Market

22.1. Germany Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Diverticulitis Disease Market

23.1. France Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Diverticulitis Disease Market

24.1. Italy Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Diverticulitis Disease Market

25.1. Spain Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Diverticulitis Disease Market

26.1. Eastern Europe Diverticulitis Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Diverticulitis Disease Market

27.1. Russia Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Diverticulitis Disease Market

28.1. North America Diverticulitis Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Diverticulitis Disease Market

29.1. USA Diverticulitis Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Diverticulitis Disease Market

30.1. Canada Diverticulitis Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Diverticulitis Disease Market

31.1. South America Diverticulitis Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Diverticulitis Disease Market

32.1. Brazil Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Diverticulitis Disease Market

33.1. Middle East Diverticulitis Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Diverticulitis Disease Market

34.1. Africa Diverticulitis Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Diverticulitis Disease Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Diverticulitis Disease Market Regulatory and Investment Landscape

36. Diverticulitis Disease Market Competitive Landscape And Company Profiles

36.1. Diverticulitis Disease Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Diverticulitis Disease Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Diverticulitis Disease Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Diverticulitis Disease Market Other Major And Innovative Companies

Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd.

38. Global Diverticulitis Disease Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Diverticulitis Disease Market

40. Diverticulitis Disease Market High Potential Countries, Segments and Strategies

40.1 Diverticulitis Disease Market In 2030 - Countries Offering Most New Opportunities

40.2 Diverticulitis Disease Market In 2030 - Segments Offering Most New Opportunities

40.3 Diverticulitis Disease Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Diverticulitis Disease Market, Overview Of Key Products - Product Examples
  • Table 2: Global Diverticulitis Disease Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Diverticulitis Disease Market, Supply Chain Analysis
  • Table 4: Global Diverticulitis Disease Market, Major Raw Material Providers
  • Table 5: Global Diverticulitis Disease Market, Major Resource Providers
  • Table 6: Global Diverticulitis Disease Market, Major Manufacturers (Suppliers)
  • Table 7: Global Diverticulitis Disease Market, Major Distributors And Channel Partners
  • Table 8: Global Diverticulitis Disease Market, Key Technologies & Future Trends
  • Table 9: Global Diverticulitis Disease Market, Major Trends
  • Table 10: Global Diverticulitis Disease Market, Major End Users
  • Table 11: Global Diverticulitis Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Diverticulitis Disease Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Diverticulitis Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Diverticulitis Disease Market - TAM, US$ Billion, 2025
  • Table 15: Global Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Diverticulitis Disease Market, Sub-Segmentation Of Uncomplicated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Diverticulitis Disease Market, Sub-Segmentation Of Complicated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Diverticulitis Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Diverticulitis Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Diverticulitis Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Diverticulitis Disease Market - Company Scoring Matrix
  • Table 97: Pfizer Inc. Financial Performance
  • Table 98: Johnson and Johnson Financial Performance
  • Table 99: F. Hoffmann-La Roche AG Financial Performance
  • Table 100: Merck & Co. Inc. Financial Performance
  • Table 101: AbbVie Inc. Financial Performance
  • Table 102: Global Diverticulitis Disease Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Diverticulitis Disease Market, Competitive Dashboard
  • Table 104: Global Diverticulitis Disease Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Diverticulitis Disease Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 106: Global, Diverticulitis Disease Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Table 107: Global, Diverticulitis Disease Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

List Of Figures

    Figure 1: Global Diverticulitis Disease Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Diverticulitis Disease Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Diverticulitis Disease Market, Supply Chain Analysis
  • Figure 4: Global Diverticulitis Disease Market, Major Raw Material Providers
  • Figure 5: Global Diverticulitis Disease Market, Major Resource Providers
  • Figure 6: Global Diverticulitis Disease Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Diverticulitis Disease Market, Major Distributors And Channel Partners
  • Figure 8: Global Diverticulitis Disease Market, Key Technologies & Future Trends
  • Figure 9: Global Diverticulitis Disease Market, Major Trends
  • Figure 10: Global Diverticulitis Disease Market, Major End Users
  • Figure 11: Global Diverticulitis Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Diverticulitis Disease Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Diverticulitis Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Diverticulitis Disease Market - TAM, US$ Billion, 2025
  • Figure 15: Global Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Diverticulitis Disease Market, Sub-Segmentation Of Uncomplicated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Diverticulitis Disease Market, Sub-Segmentation Of Complicated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Diverticulitis Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Diverticulitis Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Diverticulitis Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Diverticulitis Disease Market - Company Scoring Matrix
  • Figure 97: Pfizer Inc. Financial Performance
  • Figure 98: Johnson and Johnson Financial Performance
  • Figure 99: F. Hoffmann-La Roche AG Financial Performance
  • Figure 100: Merck & Co. Inc. Financial Performance
  • Figure 101: AbbVie Inc. Financial Performance
  • Figure 102: Global Diverticulitis Disease Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Diverticulitis Disease Market, Competitive Dashboard
  • Figure 104: Global Diverticulitis Disease Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Diverticulitis Disease Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 106: Global, Diverticulitis Disease Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Figure 107: Global, Diverticulitis Disease Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Frequently Asked Questions

The Diverticulitis Disease market was valued at $2.02 billion in 2025, increased to $2.21 billion in 2026, and is projected to reach $3.22 billion by 2030. request a sample here

The global Diverticulitis Disease market is expected to grow at a CAGR of 9.9% from 2026 to 2035 to reach $3.22 billion by 2035. request a sample here

Some Key Players in the Diverticulitis Disease market Include, Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd. . request a sample here

Major trend in this market includes: Innovative Drug Development Spurs Advances In Diverticulitis Treatments. For further insights on this market. request a sample here

North America was the largest region in the diverticulitis disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diverticulitis disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Major companies operating in the Diverticulitis Disease Market Report 2026 market are Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd. request a sample here.

North America was the largest region in the diverticulitis disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diverticulitis disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts